These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2165734)
41. Erratum: Cannabis and tolerance: acute drug impairment as a function of cannabis use history. Ramaekers JG; van Wel JH; Spronk DB; Toennes SW; Kuypers KP; Theunissen EL; Verkes RJ Sci Rep; 2016 Sep; 6():31939. PubMed ID: 27585721 [No Abstract] [Full Text] [Related]
42. Are We Using the Right Model of Cannabis Tolerance? Johnson MB J Stud Alcohol Drugs; 2016 Nov; 77(6):992-993. PubMed ID: 27797703 [No Abstract] [Full Text] [Related]
43. Aspects of tolerance to and dependence on cannabis. Wikler A Ann N Y Acad Sci; 1976; 282():126-47. PubMed ID: 828472 [TBL] [Abstract][Full Text] [Related]
44. Clinical relevance of cannabis tolerance and dependence. Jones RT; Benowitz NL; Herning RI J Clin Pharmacol; 1981; 21(S1):143S-152S. PubMed ID: 6271820 [TBL] [Abstract][Full Text] [Related]
45. Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases. Thapa D; Warne LN; Falasca M Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834122 [TBL] [Abstract][Full Text] [Related]
48. Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice. Wilson CD; Tai S; Ewing L; Crane J; Lockhart T; Fujiwara R; Radominska-Pandya A; Fantegrossi WE J Pharmacol Exp Ther; 2019 Feb; 368(2):146-156. PubMed ID: 30420360 [TBL] [Abstract][Full Text] [Related]
49. Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction? Johnson KA; Lovinger DM Front Cell Neurosci; 2016; 10():264. PubMed ID: 27891077 [TBL] [Abstract][Full Text] [Related]
50. Cannabis Epidemiology: A Selective Review. Anthony JC; Lopez-Quintero C; Alshaarawy O Curr Pharm Des; 2017 Jan; 22(42):6340-6352. PubMed ID: 27526792 [TBL] [Abstract][Full Text] [Related]
51. The impact of gonadal hormones on cannabinoid dependence. Marusich JA; Craft RM; Lefever TW; Wiley JL Exp Clin Psychopharmacol; 2015 Aug; 23(4):206-16. PubMed ID: 26237318 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of sex differences in cannabinoid dependence. Marusich JA; Lefever TW; Antonazzo KR; Craft RM; Wiley JL Drug Alcohol Depend; 2014 Apr; 137():20-8. PubMed ID: 24582909 [TBL] [Abstract][Full Text] [Related]
53. Behavioral treatment for marijuana dependence: randomized trial of contingency management and self-efficacy enhancement. Litt MD; Kadden RM; Petry NM Addict Behav; 2013 Mar; 38(3):1764-75. PubMed ID: 23254227 [TBL] [Abstract][Full Text] [Related]
54. To breed or not to breed? Empirical evaluation of drug effects in adolescent rats. Wiley JL; Evans RL Int J Dev Neurosci; 2009 Feb; 27(1):9-20. PubMed ID: 19041390 [TBL] [Abstract][Full Text] [Related]
55. The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats. Bortolato M; Aru GN; Frau R; Orrù M; Luckey GC; Boi G; Gessa GL Psychopharmacology (Berl); 2005 Jan; 177(3):264-71. PubMed ID: 15290008 [TBL] [Abstract][Full Text] [Related]
56. Cannabinoids in multiple sclerosis: do they have a therapeutic role? Killestein J; Uitdehaag BM; Polman CH Drugs; 2004; 64(1):1-11. PubMed ID: 14723555 [TBL] [Abstract][Full Text] [Related]